MAPT and Alzheimer disease: In AD, miRNAs are known to modulate the MAPK signaling pathway, thereby contributing to Aβ and tau pathology, oxidative stress, neuroinflammation, and neuronal death (Raffaele et al. 2023; Zhang et al. 2014; Bazrgar et al. 2020).